Beta Bionics Inc.
Organization details
- Legal name
- Beta Bionics Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 3841 — Surgical & Medical Instruments & Apparatus
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Irvine
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- BBNX
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001674632
- EIN
- 47-5386878
Board of directors
-
Adam Lezack · DirectorSince 2025
-
Christy Jones · DirectorSince 2025
-
Danny L. Dearen · DirectorSince 2025
-
Gerard J. Michel · DirectorSince 2025
-
Maria Palasis · DirectorSince 2025
-
Sean Carney · DirectorSince 2025
-
Sean Saint · Director · President & CEOSince 2025
Chief executives
Outstanding · grade A+
Out of 100, from shareholder return, dividends, growth and acquisitions.
Partial: only 20% of the scoring weight is on file.
- Revenue growth 20%
- 100
53.9% a year in revenue
20% of the scoring weight is on file. Figures cover December 2024 – December 2025.
Director election results
Annual meeting of May 21, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
82.7%
-
98.1%
Board connections
2 of this board's directors also sit on 2 other boards. 2 are in the same sector.
-
Delcath Systems Inc. Same sectorvia Gerard J. Michel
-
InspireMD Inc. Same sectorvia Danny L. Dearen
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $4,580,490
- 51 sales by 8 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 5, 2026 | Feider Stephen Officer (Chief Financial Officer) | Option exercise | +382 | $5.10 | $1,948 |
| Nov 5, 2026 | Feider Stephen Officer (Chief Financial Officer) | Open-market sale | −382 | $17.04 | $6,508 |
| Nov 2, 2026 | Hopman Mark Officer (Chief Commercial Officer) | Open-market sale | −370 | $16.90 | $6,253 |
| Oct 27, 2026 | Mensinger Mike Officer (Chief Product Officer) | Open-market sale | −2,650 | $22.00 | $58,300 |
| Oct 26, 2026 | Hopman Mark Officer (Chief Commercial Officer) | Open-market sale | −821 | $20.00 | $16,420 |
| Oct 14, 2026 | Hopman Mark Officer (Chief Commercial Officer) | Open-market sale | −775 | $17.35 | $13,446 |
| Oct 1, 2026 | Hopman Mark Officer (Chief Commercial Officer) | Open-market sale | −370 | $18.96 | $7,015 |
| Sep 22, 2026 | Christy Jones Director | Open-market sale | −6,430 | $23.00 | $147,890 |
| Sep 16, 2026 | Hopman Mark Officer (Chief Commercial Officer) | Open-market sale | −30,779 | $20.13 | $619,581 |
| Sep 16, 2026 | Mensinger Mike Officer (Chief Product Officer) | Open-market sale | −2,650 | $22.00 | $58,300 |
| Sep 14, 2026 | Hopman Mark Officer (Chief Commercial Officer) | Open-market sale | −775 | $15.52 | $12,028 |
| Sep 9, 2026 | Hopman Mark Officer (Chief Commercial Officer) | Open-market sale | −36,870 | $18.46 | $680,620 |
| Sep 3, 2026 | Sean Saint Director, Officer (President & CEO) | Open-market sale | −5,641 | $20.08 | $113,271 |
| Sep 2, 2026 | Hopman Mark Officer (Chief Commercial Officer) | Open-market sale | −5,327 | $19.11 | $101,799 |
| Sep 2, 2026 | Mensinger Mike Officer (Chief Product Officer) | Open-market sale | −4,375 | $19.11 | $83,606 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Beta Bionics Inc.
Who is the CEO of Beta Bionics Inc.?
Sean Saint has been Beta Bionics Inc.'s President & CEO since January 2025.
How many directors are on Beta Bionics Inc.'s board?
Beta Bionics Inc.'s board has 7 directors: Adam Lezack, Christy Jones, Danny L. Dearen, Gerard J. Michel, Maria Palasis, Sean Carney and Sean Saint.
Are Beta Bionics Inc. insiders buying or selling shares?
Over the last 12 months, Beta Bionics Inc. insiders made no open-market purchases and sold $4.6 million of shares in 51 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="beta-bionics-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.